Copertina

Disease‐modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Erika L. Hellenbart, Heather J. Ipema, Mary C. Rodriguez‐Ziccardi, Hema Krishna, Robert J. DiDomenico
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Current and emerging PCSK9‐directed therapies to reduce LDL‐C and ASCVD risk: A state‐of‐the‐art review
di: Candice L. Garwood, et al.
Pubblicazione: (2024)

Corticosteroids in critically ill patients: A narrative review
di: Bradley J. Haan, et al.
Pubblicazione: (2024)

Prevalence of potentially inappropriately prescribed medications among older adults receiving peritoneal dialysis
di: Armando Silva Almodovar, et al.
Pubblicazione: (2025)

Exploring variations in recommended first‐choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity
di: Kathryn Sine, et al.
Pubblicazione: (2024)

Prevalence of prescription medication use that can exacerbate heart failure among US adults with heart failure
di: Alexander R. Zheutlin, et al.
Pubblicazione: (2025)

Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
di: Elizabeth M. Sherman, et al.
Pubblicazione: (2024)

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
di: Jennifer N. Clements, et al.
Pubblicazione: (2026)

Platelet glycoprotein IIb/IIIa antagonists in ischemic stroke patients without endovascular therapy: A meta‐analysis
di: Dongjun Xu, et al.
Pubblicazione: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
di: Lisa T. Hong, et al.
Pubblicazione: (2024)

Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy
di: Elmar R. Alizadeh, et al.
Pubblicazione: (2024)

Combination eravacycline therapy for ventilator‐associated pneumonia due to carbapenem‐resistant Acinetobacter baumannii in patients with COVID‐19: A case series
di: Melissa N. W. Jackson, et al.
Pubblicazione: (2024)

Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease
di: Zachary P. Brehm, et al.
Pubblicazione: (2025)

Correction to “International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists”
Pubblicazione: (2024)

Response to Comment on “Acute Pharmacodynamic Effects of Oral Levodopa on Blood Pressure in Parkinson’s Disease”
di: Katherine Longardner, et al.
Pubblicazione: (2026)

Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Proteinuria in Kidney Transplant Recipients
di: Stephanie Shabanowitz, et al.
Pubblicazione: (2026)

Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis
di: Daniela Gorski, et al.
Pubblicazione: (2025)

Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases
di: Sandra L. Kane‐Gill
Pubblicazione: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
di: Yi‐Fan Chien, et al.
Pubblicazione: (2025)

SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
di: Erin F. Barreto, et al.
Pubblicazione: (2026)

Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
di: Tyler Chanas, et al.
Pubblicazione: (2024)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
di: Carlos Augusto Espinoza Cobeñas
Pubblicazione: (2024)

External Validation of the Fraser Equation for Estimation of Free Valproate Concentrations in Critically Ill Adults
di: Andrew J. Webb, et al.
Pubblicazione: (2025)

Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM
di: Dana J. Holger, et al.
Pubblicazione: (2024)

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort
di: Eleonora Camilleri, et al.
Pubblicazione: (2024)

Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy
di: Ashwin Karanam, et al.
Pubblicazione: (2025)

High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐ II Receptor Blockers ( ARBs ) Initiators
di: Asinamai M. Ndai, et al.
Pubblicazione: (2025)

The Use of Plasma Exchange for Clozapine Intoxication: A Case Report
di: Bradley J. Peters, et al.
Pubblicazione: (2025)

Severe Persistent Urinary Retention Following Treatment With Intravenous Lecanemab
di: Amber N. Navarra, et al.
Pubblicazione: (2025)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
di: Maryam Aghakouchakzadeh, et al.
Pubblicazione: (2026)

Update and narrative review of avian influenza (H5N1) infection in adult patients
di: Mohammed Aldhaeefi, et al.
Pubblicazione: (2024)

Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge
di: Christen J. Arena, et al.
Pubblicazione: (2025)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
di: Mohammed Al Musawa, et al.
Pubblicazione: (2024)

Bayesian Dosing Simulator ( BDS ): A Pharmacokinetic Modeling Tool for Optimized Antibiotic Therapy
di: Adrian Valadez, et al.
Pubblicazione: (2026)

Machine Learning Algorithms for Predicting Injurious Fall Risk Among Older Adults With Depression: A Prognostic Modeling Study
di: Grace Hsin‐Min Wang, et al.
Pubblicazione: (2025)

Scoping review of drug dosing recommendations in sustained low‐efficiency dialysis
di: Nicholas R. Nelson, et al.
Pubblicazione: (2024)

Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population‐based study
di: Mennatullah Hasan, et al.
Pubblicazione: (2024)

Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns
di: Jay D. Olivet, et al.
Pubblicazione: (2025)

Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
di: Ashlan J. Kunz Coyne, et al.
Pubblicazione: (2026)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
di: Nihal El Rouby, et al.
Pubblicazione: (2025)

Association of Human Leucocyte Antigen with Tacrolimus Pharmacokinetics in Renal Transplant Patients
di: Rashmi J. Hemani, et al.
Pubblicazione: (2026)